# NovaCardia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novacardia

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Total disclosed funding: $66M
- Latest round: Series B (Mar 20, 2007)
- Investors on record: 6

## About

Based in California, US, NovaCardia, Inc. operates as a pharmaceutical company that engages in development of drugs to treat cardiovascular diseases.

## Funding rounds

- Series B, Mar 20, 2007, $18M — Domain Associates, Forward Ventures, InterWest Partners, Versant Ventures, Skyline Ventures, Montreux Equity Partners
- Series B, Sep 21, 2006, $48M — Domain Associates, Forward Ventures, InterWest Partners, Versant Ventures, Skyline Ventures, Montreux Equity Partners

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B
- Forward Ventures (https://capitalatlas.ai/funds/forward-ventures) — Series B
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series B
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series B
- Skyline Ventures (https://capitalatlas.ai/funds/skyline-ventures) — Series B
- Montreux Equity Partners (https://capitalatlas.ai/funds/montreux-equity-partners) — Series B